Mass Balance Study of [14C]Chiauranib
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
- Status
- SUSPENDED
- Phase
- PHASE2
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
- Status
- RECRUITING
- Phase
- N/A
An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese
- Status
- UNKNOWN
- Phase
- PHASE2
Circulating EV Long RNA Profiles in SCLC
- Status
- UNKNOWN
- Phase
- NA
Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)
- Status
- COMPLETED
- Phase
- PHASE2
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
- Status
- COMPLETED
- Phase
- N/A
A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2